204 results
Page 2 of 11
20-F/A
ya6 xod9g
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
7em4a4pn 5xikqkvg
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
spswcc9t13 pmek8oer
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
haagd
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
r7qb1pw qhr
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
nco2p
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
lq2yce53e79gtrgts oa
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
ccgyo pcw
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
qg8cx6j2e
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
eq5r4ghmgia4v
17 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
12:35pm
6-K
EX-99.1
tdcrtmt
2 Jun 22
Replicel Life Sciences Inc. Provides Default Status Update
2:03pm
6-K
EX-99.1
5okox ckdw
17 May 22
Replicel Life Sciences Inc. Provides Default Status Update
6:51pm
6-K
EX-99.1
5slmq
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
p0zw3yfsn4j
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.4
qjewsm408e39fqlgcl8
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
kqioiovdn6 da
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
abntngjxm8n54e2a
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
h6um5n0s1160czui
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.3
reatkdch9
21 Dec 21
51-102F3 Material Change Report
5:28pm